Trial Profile
A multicenter prospective cohort study assessing cardiac function of sunitinib patients with metastatic renal cell carcinoma
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 11 Aug 2016
Price :
$35
*
At a glance
- Drugs Sunitinib (Primary)
- Indications Renal cell carcinoma
- Focus Adverse reactions
- 11 Aug 2016 New trial record